More healthcare entities now conduct research and boundaries between preclinical and clinical research are blurring. Academic/private partnerships are increasing. Preclinical research is often focused on emerging therapies such as gene treatments and stem cell products. Translational medicine is an emerging field focused on the rapid transition of basic research discoveries into clinical settings to better predict, prevent, diagnose, and treat disease. While cutting edge medicine holds much promise, there is a great deal of uncertainty about associated risks. This session explores the risks associated with translational research and translational medicine and the possible risk treatments that help reduce loss exposure.